- Home
- CYCCP vs BAP Comparison
CYCCP vs BAP Comparison
Compare CYCCP & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCCP
- BAP
- Stock Information
- Founded
- CYCCP N/A
- BAP 1889
- Country
- CYCCP United States
- BAP Peru
- Employees
- CYCCP 12
- BAP N/A
- Industry
- CYCCP Biotechnology: Pharmaceutical Preparations
- BAP Major Banks
- Sector
- CYCCP Health Care
- BAP Finance
- Exchange
- CYCCP Nasdaq
- BAP Nasdaq
- Market Cap
- CYCCP N/A
- BAP N/A
- IPO Year
- CYCCP N/A
- BAP 1995
- Fundamental
- Price
- CYCCP $6.94
- BAP $198.66
- Analyst Decision
- CYCCP
- BAP Hold
- Analyst Count
- CYCCP 0
- BAP 3
- Target Price
- CYCCP N/A
- BAP $189.67
- AVG Volume (30 Days)
- CYCCP N/A
- BAP 202.7K
- Earning Date
- CYCCP N/A
- BAP 11-07-2024
- Dividend Yield
- CYCCP N/A
- BAP 1.93%
- EPS Growth
- CYCCP N/A
- BAP 3.65
- EPS
- CYCCP N/A
- BAP 17.61
- Revenue
- CYCCP N/A
- BAP $4,667,680,981.00
- Revenue This Year
- CYCCP N/A
- BAP N/A
- Revenue Next Year
- CYCCP N/A
- BAP $6.65
- P/E Ratio
- CYCCP N/A
- BAP $10.95
- Revenue Growth
- CYCCP N/A
- BAP 8.67
- 52 Week Low
- CYCCP N/A
- BAP $122.73
- 52 Week High
- CYCCP N/A
- BAP $199.99
- Technical
- Relative Strength Index (RSI)
- CYCCP 50.02
- BAP 72.68
- Support Level
- CYCCP $5.58
- BAP $190.81
- Resistance Level
- CYCCP $7.07
- BAP $196.00
- Average True Range (ATR)
- CYCCP 0.17
- BAP 4.66
- MACD
- CYCCP 0.03
- BAP 1.04
- Stochastic Oscillator
- CYCCP 70.83
- BAP 94.50
About CYCCP Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.